Redox Webinar Series 2022
Redox2022 Webinar detailed Programme
Tuesday 26 April 2022 - NRF2 and vascular diseases
Organized in cooperation with the COST action CA20121
“Bench to Bedside transition for Pharmacological regulation of NRF2 in non communicable diseases”
Novel atypical functions of Nrf2 and Keap1 in endothelial cells
by Anna Grochot-Przeczek. Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
The NRF2-KEAP1 signaling pathway as a pharmacological target in cardiovascular and neuropsychiatric complications in response to environmental risk factors traffic noise and particulate matter
by Andreas Daiber. Department of Cardiology 1, Laboratory of Molecular Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
Transcriptional Activation of NRF2 Defense Genes is Attenuated in Vascular Cells under Physiological Normoxia: Consequences for Reperfusion Injury
by Giovanni E. Mann. British Heart Foundation Centre of Research Excellence, Faculty of Life Sciences & Medicine, King’s College London, London SE1 9NH, U.K.